Alnylam Pharmace. buy WatchMen
Start price
16.10.19
/
50%
€73.50
Target price
09.02.20
-
Performance (%)
54.50%
End price
09.02.20
€113.56
Summary
This prediction ended on 09.02.20 with a price of €113.56. With a performance of 54.50% the BUY prediction by WatchMen was a big success. WatchMen has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 4.465% | 4.465% | 36.140% | 55.232% |
| iShares Core DAX® | 4,24 % | 2,86 % | 14,03 % | 49,55 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % | 32,71 % | 85,97 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % | 48,30 % | 63,32 % |
| iShares S&P 500 | 3,53 % | 1,95 % | 25,25 % | 62,38 % |
Comments by WatchMen for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.